학술논문
A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases
Document Type
Review Article
Author
Source
In Acta Pharmaceutica Sinica B April 2024
Subject
Language
ISSN
2211-3835